1. Home
  2. BIAF vs AEHL Comparison

BIAF vs AEHL Comparison

Compare BIAF & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • AEHL
  • Stock Information
  • Founded
  • BIAF 2014
  • AEHL 1993
  • Country
  • BIAF United States
  • AEHL China
  • Employees
  • BIAF N/A
  • AEHL N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • AEHL Building Materials
  • Sector
  • BIAF Health Care
  • AEHL Industrials
  • Exchange
  • BIAF Nasdaq
  • AEHL Nasdaq
  • Market Cap
  • BIAF 12.2M
  • AEHL 11.6M
  • IPO Year
  • BIAF 2022
  • AEHL 2007
  • Fundamental
  • Price
  • BIAF $0.35
  • AEHL $4.06
  • Analyst Decision
  • BIAF Hold
  • AEHL
  • Analyst Count
  • BIAF 1
  • AEHL 0
  • Target Price
  • BIAF N/A
  • AEHL N/A
  • AVG Volume (30 Days)
  • BIAF 12.3M
  • AEHL 44.0K
  • Earning Date
  • BIAF 08-13-2025
  • AEHL 05-01-2025
  • Dividend Yield
  • BIAF N/A
  • AEHL N/A
  • EPS Growth
  • BIAF N/A
  • AEHL N/A
  • EPS
  • BIAF N/A
  • AEHL N/A
  • Revenue
  • BIAF $8,809,228.00
  • AEHL $98,773,000.00
  • Revenue This Year
  • BIAF N/A
  • AEHL N/A
  • Revenue Next Year
  • BIAF $20.00
  • AEHL N/A
  • P/E Ratio
  • BIAF N/A
  • AEHL N/A
  • Revenue Growth
  • BIAF 78.40
  • AEHL 36.99
  • 52 Week Low
  • BIAF $0.16
  • AEHL $1.79
  • 52 Week High
  • BIAF $2.99
  • AEHL $193.20
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 56.35
  • AEHL 72.49
  • Support Level
  • BIAF $0.27
  • AEHL $3.53
  • Resistance Level
  • BIAF $0.38
  • AEHL $4.43
  • Average True Range (ATR)
  • BIAF 0.04
  • AEHL 0.32
  • MACD
  • BIAF 0.01
  • AEHL 0.06
  • Stochastic Oscillator
  • BIAF 73.43
  • AEHL 75.63

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

Share on Social Networks: